During the pathogenesis of CLL, CXCL12 activates protein tyrosine kinase (PTK), Bruton’s tyrosine kinase (BTK), and Janus Kinase (JAK), which in turn activate the small GTPase RhoA (132). This evidence concerns the gene CXCL12 and B-cell chronic lymphocytic leukemia.